HIGHLIGHTS
- who: Dapagliflozin et al. from the C The Author(s) Published by Oxford University Press on behalf of the European Society of CardiologyPhysics, Ninewells Hospital and Medical School, Dundee , SY, UK have published the research work: A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial, in the Journal: (JOURNAL)
- what: The study was approved by the East of Scotland Research Ethics Committee (16/ES/0131) and all participants provided written informed consent to participate in the study and were enrolled in this trial for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.